Anti-tissue factor antibodies, antibody-drug conjugates, and related methods
US11447566B2 · kind B2 · utility
1Cited by
105References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 26, 2021 |
| Grant date | Sep 20, 2022 |
| Priority date | — |
| Expiry date | Aug 26, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/7454
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are antibodies that specifically bind to human tissue factor (TF), anti-TF antibody-drug conjugates (ADCs), and compositions comprising the antibodies or ADCs. Also provided herein are methods of making and using the antibodies or ADCs, such as therapeutic and diagnostic methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.